Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 227, Issue 6
Volume 227, Issue 6
15 March 2023
ISSN 0022-1899
EISSN 1537-6613

Volume 227, Issue 6, 15 March 2023

Editorial Commentary

Eleanor C Semmes and Sallie R Permar
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 739–741, https://doi.org/10.1093/infdis/jiac308

Major Articles

Viruses

Diego Forni and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 742–751, https://doi.org/10.1093/infdis/jiac298

Within the endemic region, MPXV clades show distinctive geographic structuring of genetic diversity. Separation of major lineages occurred in a period ranging from the Medieval Warm Period to the Little Ice Age, which was characterized by changes in rainforest coverage.

Jill-Léa Ramassamy and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 752–760, https://doi.org/10.1093/infdis/jiac312

Among 3,400 rural adult participants from East Cameroon, HTLV-1 prevalence was 1.1%. Independent factors associated with the infection were Pygmy ethnicity, history of surgery and non-human primate bite, suggesting both nosocomial and zoonotic transmission of HTLV-1 in this region.

Isabel Leroux-Roels and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 761–772, https://doi.org/10.1093/infdis/jiac327

Vaccine formulations against respiratory syncytial virus (RSV) containing the stabilized prefusion conformation of RSV fusion protein (RSVPreF3) were well tolerated and immunogenic. Based on safety/immunogenicity profiles, the AS01E-adjuvanted vaccine containing 120 μg of RSVPreF3 was selected for further clinical development.

Covid-2019

Kayoko Shioda and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 773–779, https://doi.org/10.1093/infdis/jiac483

Vaccination with the primary series was strongly associated with reduction in COVID-19 mortality at state level in the Alpha, Delta, and Omicron wave. This effect did not vary by the state-level seroprevalence or estimated proportion of the population ever infected.

Yu Nakagama and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 780–787, https://doi.org/10.1093/infdis/jiac492

Avidity maturation augments host immunity following a natural infection and/or vaccination. For protection against SARS-CoV-2, avidity maturation was progressive beyond acute recovery from infection or became apparent after the booster vaccine dose, and granted broader neutralizing capacity against variant strains.

Yaya Chu and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 788–799, https://doi.org/10.1093/infdis/jiac500

Highly functional SARS-CoV-2–vCTLs can be rapidly generated from convalescent COVID-19 donors using the CliniMACS Cytokine Capture System. SARS-CoV-2–vCTLs displayed a highly diverse TCR repertoire, enhanced memory CD8 and CD4 T cells, and increased gene expression in T-cell function and other pathways.

Nicole E Winchester and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 800–805, https://doi.org/10.1093/infdis/jiad003

Severe acute respiratory syndrome coronavirus 2 infection during Delta predominance provided no significant protection against BA.4/BA.5 infection and minimal protection against hospitalization with BA.4/BA.5. Conversely, prior infection during BA.1/BA.2 and up-to-date vaccination provided modest protection against BA.4/BA.5 infection and hospitalization.

Bacteria

Ying Xie and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 806–819, https://doi.org/10.1093/infdis/jiad008

Postmenopausal women may be subjected to an increased risk of CDI hospitalization. A deficiency of endogenous estrogen and dietary soy isoflavones increased the mortality of mice with CDI. The most prominent component of soy isoflavone, genistein, protects against CDI.

Wilhelm Hedin and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 820–827, https://doi.org/10.1093/infdis/jiad007

In this retrospective cohort study, a rough colony morphology of Mycobacterium abscessus complex was associated with poor treatment outcome, cavitary disease, and cough as a presenting symptom in the study participants, as compared to those with smooth isolates.

Viewpoint

Rahul M Kohli and Stuart N Isaacs
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 828–830, https://doi.org/10.1093/infdis/jiac471

Correspondence

Guillaume Thouvenin and others
The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Pages 831–832, https://doi.org/10.1093/infdis/jiac328

Correction

The Journal of Infectious Diseases, Volume 227, Issue 6, 15 March 2023, Page 833, https://doi.org/10.1093/infdis/jiac373
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close